Long-Term Effects of Individual Mindfulness-Based Cognitive Therapy and Cognitive Behavior Therapy for Depressive Symptoms in Patients with Diabetes: A Randomized Trial
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Depressive symptoms are very common in patients with diabetes, and this comorbidity negatively influences the patients' medical outcomes and mortality [1]. The burden of depression is intensified by its chronic course trajectory, as a substantial number of patients show a relapse of their symptoms after having recovered [2]. These high relapse rates warrant identifying psychological treatments that reduce depressive symptoms not only directly after the intervention, but that also ensure the maintenance of well-being in the long term.Mindfulness-based cognitive therapy (MBCT) is a potential effective psychological intervention for treating current depressive symptoms and also for relapse prevention treatment [3,4]. Recent research has called for MBCT to be compared not only to passive control conditions but also to active treatments [5]. Hence, in a recent randomized controlled trial in patients with diabetes, we compared the direct effects of MBCT not only to a waiting list control condition, but also to cognitive behavior therapy (CBT), the most frequently applied and evidence-based treatment for depressive symptoms [6]. We found that both MBCT and CBT were effective in reducing the severity of depressive symptoms, anxiety and diabetes-related distress as well as in increasing well-being.The current study focuses on the long-term effects of both treatments. We hypothesized that reductions in depressive symptoms achieved directly after MBCT and CBT would be sustained during the 9-month follow-up period.The design and methods of the study have been discussed in detail elsewhere [6]. The original study included 94 adult patients with diabetes type 1 or 2 and comorbid depressive symptoms [i.e. Beck Depression Inventory II (BDI-II) score ≥14]. The patients were randomly assigned to either MBCT, CBT or a waiting list condition. After the waiting period, participants who still had depressive symptoms (n = 28) were again randomized to either MBCT or CBT and combined with the original sample, yielding the current sample size of 91, with 45 patients receiving MBCT and 46 CBT. Both MBCT and CBT were protocolized interventions delivered individually in 8 weekly sessions of approximately 60 min.Assessments were held before and after the treatment and at 3 and 9 months after the treatment. The outcome measures are described in detail elsewhere [6]. The primary outcome measure, the severity of depressive symptoms, was measured with the BDI-II. Secondary outcomes were well-being, as assessed with the WHO-5 Well-Being Index; anxiety, as assessed with the Generalized Anxiety Disorder 7 questionnaire (GAD-7), and diabetes-related distress, as measured with the Problem Areas in Diabetes questionnaire (PAID). Finally, the glycemic control, indicated by glycated hemoglobin (HbA1c) values, was retrieved from the patients' records. As pretreatment value, the average of all assembled values of 0-6 months prior to the intervention was used, and as postmeasurement value we used the average of all values between 1 and 6 months after the intervention. For the HbA1c, we only used 1 follow-up measurement, averaging all values between 6 and 12 months after the intervention.All analyses were carried out on an intention-to-treat basis, and missing values were imputed by means of multiple imputations. The longitudinal development of primary and secondary outcome measures was analyzed using linear mixed models.Of the 91 patients who entered MBCT and CBT, 12 patients in each condition completed fewer than 6 of the 8 sessions and were considered dropouts. Six participants in the MBCT condition and 7 participants in the CBT condition did not fill out the questionnaire after the measurement. At the 3-month follow-up, 12 patients in the MBCT condition and 11 in the CBT condition failed to complete the measurements and 16 and 14 patients, respectively, at the 9-month follow-up. Missing observations did not significantly differ as a function of the treatment.The results of the analyses are presented in table 1. For the primary outcome measure, the severity of depressive symptoms, there was a significant effect of time in both conditions. The results of post hoc tests indicated that depressive symptoms were significantly reduced from before the treatment to after the treatment (MBCT: p < 0.001; CBT: p < 0.001), but not from after the treatment to the 3- or 9-month follow-up (MBCT: p = 0.27-0.46; CBT: p = 0.34-0.75). For the secondary psychological outcomes, the analyses also showed a significant effect of MBCT and CBT over time, with an improvement from before the treatment to after the treatment that was sustained up to the last follow-up. In contrast, analyses showed no significant effect on HbA1c over time. For all primary and secondary outcome measures, no significant interactions between time and group were found.This is the first study to examine and compare the long-term effects of MBCT and CBT as treatments for depressive symptoms in patient
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fjorback, L. O., Arendt, M., Ørnbøl, E., Fink, P., & Walach, H. (2011) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01704.x · Cited by 803
Chiesa, A., & Serretti, A. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2010.08.011 · Cited by 650
Vittengl, J. R., Clark, L. A., Dunn, T. W., & Jarrett, R. B. (2007) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.75.3.475 · Cited by 551
Carlson, L. E., Ursuliak, Z., Goodey, E., Angen, M., & Speca, M. (2001) · Supportive Care in Cancer · doi:10.1007/s005200000206 · Cited by 376
van Son, J., Nyklíček, I., Pop, V. J., Blonk, M. C., Erdtsieck, R. J., Spooren, P. F., Toorians, A. W., & Pouwer, F. (2013) · Diabetes Care · doi:10.2337/dc12-1477 · Cited by 169
Tovote, K. A., Fleer, J., Snippe, E., Peeters, A. C. T. M., Emmelkamp, P. M. G., Sanderman, R., Links, T. P., & Schroevers, M. J. (2014) · Diabetes Care · doi:10.2337/dc13-2918 · Cited by 163
Self-citationManicavasgar, V., Parker, G., & Perich, T. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.09.027 · Cited by 136
Galante, J., Iribarren, S. J., & Pearce, P. F. (2013) · Journal of Research in Nursing · doi:10.1177/1744987112466087 · Cited by 79
Cited by
Current Psychosomatic Practice
Fava, G. A., Cosci, F., & Sonino, N. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000448856 · Cited by 302
Loucks, E. B., Schuman-Olivier, Z., Britton, W. B., Fresco, D. M., Desbordes, G., Brewer, J. A., & Fulwiler, C. (2015) · Current Cardiology Reports · doi:10.1007/s11886-015-0668-7 · Cited by 158
Noordali, F., Cumming, J., & Thompson, J. L. (2017) · Journal of Health Psychology · doi:10.1177/1359105315620293 · Cited by 84
Principles for a Responsible Integration of Mindfulness in Individual Therapy
Michalak, J., Crane, C., Germer, C. K., Gold, E., Heidenreich, T., Mander, J., Meibert, P., & Segal, Z. V. (2019) · Mindfulness · doi:10.1007/s12671-019-01142-6 · Cited by 40
Haenen, S., Nyklíček, I., van Son, J., Pop, V., & Pouwer, F. (2016) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2016.04.006 · Cited by 38
Metadata
- Authors
- Tovote, K. A., Schroevers, M. J., Snippe, E., Sanderman, R., Links, T. P., Emmelkamp, P. M. G., & Fleer, J.
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2015
- Volume
- 84
- Issue
- 3
- Pages
- 186-187
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2020619253
- Cited by
- 35
- References
- 8
- FWCI
- 6.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.